A real-world disproportionality analysis of baloxavir marboxil: post-marketing pharmacovigilance data
In clinical application of baloxavir, attention should be paid to the new AE signals in addition to the those recorded in the labels, so as to ensure the safety of the patients.
Authors
- Junchang Ye
- Jie Zhou (ORCID: https://orcid.org/0000-0001-7006-2889)
- Maohua Chen (ORCID: https://orcid.org/0000-0001-7393-4523)
- Xinlei Zheng
Institutions
- Fujian Medical University (CN)
- Zhangzhou Municipal Hospital of Fujian Province (CN)
- Pingliang People's Hospital (CN)
- Comprehensive Clinical Research (US)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1080/14740338.2024.2393269
- Citations
- 5
- Primary Topic
- Pharmaceutical industry and healthcare
- Type
- article
- Field-Weighted Citation Impact
- 2.33